Ordering Publications
To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:
Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535
Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.
Publications List (D-G)
(A list of all publications is available as an .rtf file).
Danila, B., Annon, J. J., & Anglin, M. D. (1997). State demand
and treatment needs assessment study: Dependence and abuse of
alcohol and other drugs among California arrestees. (Contract
No. 270-92-0012). Los Angeles, CA: UCLA Drug Abuse Research Center.
(06.33)
Dekimpe, M. G., Van de Gucht, L. M., Hanssens, D. M., & Powers,
K. I. (1995). Long-run abstinence after treatment for narcotics
abuse: What are the odds? Unpublished manuscript, University of
California, Los Angeles, Drug Abuse Research Center. (18.48)
Denison, M. E., Paredes, A., & Booth, J. B. (1997). Alcohol
and cocaine interactions and aggressive behaviors. In: Recent
Developments in Alcoholism, Vol. 13: Alcohol and Violence: Epidemiology,
Neurobiology, Psychology, Family Issues (pp. 283-303). New
York, NY: Plenum Press. (02.9)
Deren, S. (1988). Parenting and drug abuse: Issues and services.
Los Angeles: Drug Abuse Information and Monitoring Project, UCLA
Drug Abuse Research Center. (11.3)
Deschenes, E. P. (1988). Cocaine use and pregnancy. Los Angeles:
Drug Abuse Information and Monitoring Project, UCLA Drug Abuse
Research Center. (21.2)
Deschenes, E. P. (1990). Longitudinal research designs. In: K.
L. Kempf (Ed.), Measurement issues in criminology (pp.
152-166). New York: Springer-Verlag. (12.13)
Deschenes, E. P., & Anglin, M. D. (1992). Effects of legal
supervision on narcotic addict behavior, ethnic and gender influences
. In: T. Mieczkowski (Ed.), Drugs, crime, and social policy
(pp. 167-196). Boston: Allyn and Bacon. (06.19)
Deschenes, E. P., Anglin, M. D., & Speckart, G. R. (1991).
Narcotics addiction: Related criminal careers, social and economic
costs. Journal of Drug Issues, 21(2), 383-411. (06.15)
Domier, C. P., Simon, S. L., Rawson, R., Huber, A., & Ling,
W. (2000). A comparison of injecting and noninjecting methamphetamine
users. Journal of Psychoactive Drugs, 32(2), 229-232.
(28.19)
Douglas, S. D., Camarca, M., Xu, J., Durako, S. J., Murphy, D.
A., Moscicki, B., & Wilson, C. M. (2003). The relationships
between substance abuse, psychosocial variables, and natural killer
cell enumeration and function in HIV-infected and high-risk uninfected
adolescents. AIDS Research and Human Retroviruses, 19(5),
399-408. (01.92)
Doverty, M., Somogyi, A. A., White, J. M., Bochner, F., Beare,
C. H., Menelaou, A., & Ling, W. (2001). Methadone maintenance
patients are cross-tolerant to the antinociceptive effects of
morphine. Pain, 93(2), 155-163. (10.40)
Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R.,
& Ling, W. (2001). Hyperalgesic responses in methadone maintenance
patients. Pain, 90(1-2), 91-96. (10.39)
Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R.,
& Ling, W. (2002). Reply to Dr. Clark's comment on Doverty
et al., hyperalgesic responses in methadone maintenance patients
(Pain 2001; 90; 91-96). Pain, 99(3),
609-610. (10.43)
Ebener, P., Saner, H., & Anglin, M. D. (1995). Building a
data and analysis infrastructure to support substance abuse policy
decisionmaking: A strategic plan. Sacramento, CA: California Department
of Alcohol and Drug Programs. (13.11)
Eisen, V., Abraham, E., Burdon, W. M., & Hurdle, F. (2000).
Community behind the walls: Challenges facing in-custody therapeutic
communities. San Francisco, CA: Walden House, Inc. (18.71)
Ernst, M., Bolla, K., Mouratidis, M., Contoreggi, C., Matochik,
J. A., Kurian, V., Cadet, J. L., Kimes, A. S., & London, E.
D. (2002). Decision-making in a risk-taking task: a PET study.
Neuropsychopharmacology, 26(5), 682-691. (30.10)
Ernst, M., Grant, S., London, E. D., Contoreggi, C., Kimes, A.
S., & Spurgeon, L. (2003). Decision making in adolescents
with behavior disorders and adults with substance abuse. American
Journal of Psychiatry, 160(1), 33-40. (05.18)
Ernst, M., Heishman, S. J., Spurgeon, L., & London, E. D.
(2001). Smoking history and nicotine effects on cognitive performance.
Neuropsychopharmacology, 25(3), 313-319. (17.3)
Ernst, M., Kimes, A. S., London, E. D., Matochik, J. A., Eldreth,
D., Tata, S., Contoreggi, C., Leff, M., & Bolla, K. (2003).
Neural substrates of decision making in adults with attention
deficit hyperactivity disorder. American Journal of Psychiatry,
160(6), 1061-1070. (30.27)
Ernst, M., Matochik, J. A., Heishman, S. J., Van Horn, J. D.,
Jons, P. H., Henningfield, J. E., & London, E. D. (2001).
Effect of nicotine on brain activation during performance of a
working memory task. Proceedings of the National Academy of
Sciences of the United States of America, 98(8), 4728-4733.
(30.12)
Falkin, G. P., Prendergast, M. L., & Anglin, M. D. (1994).
Drug treatment in the criminal justice system. Federal Probation,
58(3), 31-36. (06.12)
Falkin, G. P., Wellisch, J., Prendergast, M. L., Kilian, T. C.,
Hawke, J., Natarajan, M., Kowalewski, M. R., & Owen, B. (1994).
Drug treatment for women offenders: A systems perspective. New
York: National Development and Research Institutes, Inc.; Los
Angeles: Drug Abuse Research Center. (18.34)
Farabee, D. (2002). Reexamining Martinson's critique: A cautionary
note for evaluators. Crime and Delinquency, 48(1), 189-192.
(03.14)
Farabee, D., Joshi, V., & Anglin, M. D. (2001). Addiction
careers and criminal specialization. Crime and Delinquency,
47(2), 196-220. (06.41)
Farabee, D., & Leukefeld, C. G. (2002). HIV and AIDS prevention
strategies. In: C. G. Leukefeld, D. Farabee, & F. M. Tims
(Eds.), Treatment of Drug Offenders: Policies and Issues
(pp. 172-185, xiv, 453). New York: Springer Publishing.(01.61)
Farabee, D., & Leukefeld, C. G. (1999). Opportunities for
AIDS prevention in a rural state in criminal justice and drug
treatment settings. Substance Use and Misuse, 34(4-5),
617-631. (01.51)
Farabee, D., Leukefeld, C. G., & Hays, L. (1998). Accessing
drug abuse treatment: Perceptions of out-of-treatment injectors.
Journal of Drug Issues, 28(2), 391-394. (18.61)
Farabee, D., Monahan, G., Hegamin, A., Gil-Rivas, V., & Kalechstein,
A. (1998). Implementation of the CYA-RSAT Programs. A process
evaluation of the California Youth Authority's Residential Substance
Abuse Treatment (RSAT) Programs (Year 1). Sacramento, CA:
Office of Criminal Justice Planning and The California Department
of Youth Authority. (24.14)
Farabee, D., Prendergast, M. L., & Anglin, M. D. (1998). The
effectiveness of coerced treatment for drug-abusing offenders.
Federal Probation, 62(1), 3-10. (06.35)
Farabee, D., Prendergast, M. L., & Cartier, J. (2002). Alcohol,
the "un-drug". Psychiatric Services, 53(11),
1375-1376. (02.17)
Farabee, D., Prendergast, M. L., & Cartier, J. (2002). Methamphetamine
use and HIV risk among substance-abusing offenders in California.
Journal of Psychoactive Drugs, 34(3), 295-300. (28.20)
Farabee, D., Prendergast, M. L., Cartier, J., Wexler, H., Knight,
K., & Anglin, M. D. (1999). Barriers to implementing effective
correctional drug treatment programs. Prison Journal, 79(2),
150-162. (06.37)
Farabee, D., Rawson, R., & McCann, M. J. (2002). Adoption
of drug avoidance activities among patients in contingency management
and cognitive-behavioral treatments. Journal of Substance
Abuse Treatment, 23, 343-350. (18.105)
Farabee, D., Shen, H., Hser, Y., Grella, C. E., & Anglin,
M. D. (2001). The effect of drug treatment on criminal behavior
among adolescents in DATOS-A. Journal of Adolescent Research,
16(6), 679-696. (06.24)
Farabee, D., Shen, H., & Sanchez, S. (2002). Perceived coercion
and treatment need among mentally ill parolees. Criminal Justice
and Behavior, 29(1), 76-86. (03.15)
Farrell, M., Marsden, J., & Ling, W. (2002). Methamphetamine:
drug use and psychoses becomes a major public health issue in
the Asia Pacific region. Addiction, 97, 771-772. (28.18)
Finnerty, B. A. (2003). Monitoring and reporting alcohol and drug
use trends in California: The California Substance Abuse Research
Consortium Meetings. Journal of Psychoactive Drugs, SARC Supplement
1, 119-125. (08.10)
Fiorentine, R. (1999). After drug treatment: are 12-step programs
effective in maintaining abstinence? American Journal of Drug
and Alcohol Abuse, 25(1), 93-116. (18.82)
Fiorentine, R. (1994). Assessing drug and alcohol treatment needs
of general and special populations: Conceptual, empirical and
inferential issues. Journal of Drug Issues, 24(3), 445-462.
(18.29)
Fiorentine, R. (1993). Beyond equity in the delivery of alcohol
and drug abuse treatment services. Journal of Drug Issues, 23(4),
559-577. (18.28)
Fiorentine, R. (2001). Counseling frequency and the effectiveness
of outpatient drug treatment: revisiting the conclusion that "more
is better". American Journal of Drug and Alcohol Abuse,
27(4), 617-631. (18.97)
Fiorentine, R. (1998). Effective drug treatment: Testing the distal
needs hypothesis. Journal of Substance Abuse Treatment, 15(4),
281-289. (18.63)
Fiorentine, R., & Anglin, M. D. (1997). Does increasing the
opportunity for counseling increase the effectiveness of outpatient
drug treatment? American Journal of Drug and Alcohol Abuse,
23(3), 369-382. (18.47)
Fiorentine, R., & Anglin, M. D. (1996). More is better: Counseling
participation and the effectiveness of outpatient drug treatment.
Journal of Substance Abuse Treatment, 13(4), 341-348.
(18.50)
Fiorentine, R., & Anglin, M. D. (1994). Perceiving need for
drug treatment: A look at eight hypotheses. International
Journal of the Addictions, 29(14), 1835-1854. (18.30)
Fiorentine, R., Anglin, M. D., Gil-Rivas, V., & Taylor, E.
(1997). Drug treatment: Explaining the gender paradox. Substance
Use And Misuse, 32(6), 653-678. (18.75)
Fiorentine, R., & Hillhouse, M. P. (2001). The addicted-self
model: an explanation of "natural" recovery? Journal
of Drug Issues, 31(2), 395-415,417-423. (18.58)
Fiorentine, R., & Hillhouse, M. P. (2000). Drug treatment
and 12-step program participation: the additive effects of integrated
recovery activities. Journal of Substance Abuse Treatment,
18(1), 65-74. (18.88)
Fiorentine, R., & Hillhouse, M. P. (1999). Drug treatment
effectiveness and client-counselor empathy: Exploring the effects
of gender and ethnic congruency. Journal of Drug Issues, 29(1),
59-74. (18.84)
Fiorentine, R., & Hillhouse, M. P. (2000). Exploring the additive
effects of drug misuse treatment and twelve-step involvement:
Does twelve-step ideology matter? Substance Use and Misuse,
35(3), 367-397. (18.86)
Fiorentine, R., & Hillhouse, M. P. (2003). Replicating the
addicted-self model of recovery. Addictive Behaviors, 28,
1063-1080. (18.108)
Fiorentine, R., & Hillhouse, M. P. (2000). Self-efficacy,
expectancies, and abstinence acceptance: further evidence for
the addicted-self model of cessation of alcohol- and drug-dependent
behavior. American Journal of Drug and Alcohol Abuse, 26(4),
497-521. (18.67)
Fiorentine, R., Hillhouse, M. P., & Anglin, M. D. (2002).
Drug-use careers. In: C. G. Leukefeld, F. M. Tims, & D. Farabee
(Eds.), Treatment of Drug Offenders: Policies and Issues
(pp. 273-282, xiv, 453). New York: Springer Publishing Co. (06.42)
Fiorentine, R., Hser, Y., & Anglin, M. D. (1997). "Dabblers,"
"dealers," "stealers," and "stealer-dealers":
Criminal specialization among male narcotic users. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center. (06.27)
Fiorentine, R., Nakashima, J. D., & Anglin, M. D. (1999).
Client engagement in drug treatment. Journal of Substance
Abuse Treatment, 17(3), 199-206. (18.83)
Fiorentine, R., Pilati, M. L., & Hillhouse, M. P. (1999).
Drug treatment outcomes: investigating the long-term effects of
sexual and physical abuse histories. Journal of Psychoactive
Drugs, 31(4), 363-372. (18.85)
Fisher, D. G., & Anglin, M. D. (1987). Survival analysis in
drug program evaluation. Part I. Overall program effectiveness.
International Journal of the Addictions, 22(2), 115-134.
(16.2)
Fisher, D. G., Anglin, M. D., Weisman, C. P., & Pulliam, L.
(1989). Replication problems of substance abuser MMPI cluster
types. Multivariate Behavioral Research, 24(3), 335-352.
(12.2)
Fisher, D. G., MacKinnon, D. P., Anglin, M. D., & Thompson,
J. P. (1987). Parental influences on substance use: Gender differences
and stage theory. Journal of Drug Education, 17(1), 69-86.
(11.2)
Fletcher, B. W., & Grella, C. E. (2001). Preface to the JAR
special issue: The Drug Abuse Treatment Outcome Studies for Adolescents.
Journal of Adolescent Research, 16(6), 537-544. (05.8)
Freese, T. E., Miotto, K., & Reback, C. J. (2002). The effects
and consequences of selected club drugs. Journal of Substance
Abuse Treatment, 23(2), 151-156. (05.17)
Frosch, D. L., Nahom, D., & Shoptaw, S. (2002). Optimizing
smoking cessation outcomes among the methadone maintained. Journal
of Substance Abuse Treatment, 23, 425-430. (17.9)
Frosch, D. L., Shoptaw, S., Huber, A., Rawson, R., & Ling,
W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine
abusers. Journal of Substance Abuse Treatment, 13(6),
483-486. (28.4)
Frosch, D. L., Shoptaw, S., Jarvik, M. E., Rawson, R., & Ling,
W. (1998). Interest in smoking cessation among methadone maintained
outpatients. Journal of Addictive Diseases, 17(2), 9-19.
(10.33)
Frosch, D. L., Shoptaw, S., Nahom, D., & Jarvik, M. E. (2000).
Associations between tobacco smoking and illicit drug use among
methadone-maintained opiate-dependent individuals. Experimental
and Clinical Psychopharmacology, 8(1), 97-103. (10.35)
Fudala, P. J., Bridge, P., Herbert, S., Williford, W. O., Chiang,
N., Jones, K., Collins, H., Raisch, D., Casadonte, P., Goldsmith,
R. J., Ling, W., Malkerneker, U., McNicholas, L., Renner, J.,
Stine, S., & Tusel, D. (2003). Office-based treatment of opiate
addiction with a sublingual-tablet formulation of buprenorphine
and naloxone. New England Journal of Medicine, 349(10),
949-954. (29.27)
Galaif, E. R., Hser, Y., Grella, C. E., & Joshi, V. (2001).
Prospective risk factors and treatment outcomes among adolescents
in DATOS-A. Journal of Adolescent Research, 16(6), 661-678.
(05.9)
Gawin, F. H., Khalsa, M. E., Carroll, K., Kosten, T. R., &
Jatlow, P. (1992). Cocaine abstinence is predicted by desipramine
hydrochloride plasma concentrations. Paper presented at the Proceedings
of the 54th annual scientific meeting, the College on Problems
of Drug Dependence, Inc., Keystone, Colorado. (04.21)
Gawin, F. H., Khalsa, M. E., & Ellinwood, E. (1995). Stimulants.
In: G. Gabbard, & H. Kleber (Eds.), Treatment of psychiatric
disorders: The DSM-IV edition (pp. 706-720). Washington,
DC: American Psychiatric Association Press. (04.17)
Gil-Rivas, V., & Anglin, M. D. (1998). Patterns of substance
use and characteristics of Latino juvenile arrestees: Prevention,
treatment, and policy implications. Final report, August 17, 1998.
(09.14)
Gil-Rivas, V., Anglin, M. D., & Annon, J. J. (1997). Patterns
of drug use and criminal activities among Latino arrestees in
California: Treatment and policy implications. Journal of
Psychopathology and Behavioral Assessment, 19(2), 161-174.
(09.21)
Gil-Rivas, V., Fiorentine, R., & Anglin, M. D. (1996). Sexual
abuse, physical abuse, and posttraumatic stress disorder among
women participating in outpatient drug abuse treatment. Journal
of Psychoactive Drugs, 28(1), 95-102. (21.19)
Gil-Rivas, V., Fiorentine, R., Anglin, M. D., & Taylor, E.
(1997). Sexual and physical abuse: Do they compromise drug treatment
outcomes? Journal of Substance Abuse Treatment, 14(4),
351-358. (18.59)
Goldstein, H. M. (1989). The availability of methadone maintenance
in California. Los Angeles: Drug Abuse Information and Monitoring
Project, UCLA Drug Abuse Research Center. (10.9)
Goldstein, H. M. (1991). The effectiveness of methadone maintenance
treatment. Los Angeles: Drug Abuse Information and Monitoring
Project, UCLA Drug Abuse Research Center. (10.12)
Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers
show impaired performance in a laboratory test of decision making.
Neuropsychologia, 38(8), 1180-1187. (13.27)
Greene, S., Haney, C., & Hurtado, A. (2000). Cycles of pain:
Risk factors in the lives of incarcerated mothers and their children.
Prison Journal, 80(1), 3-23. (21.26)
Greenwell, L., & Brecht, M. L. (2003). Self-reported health
status among treated methamphetamine users. American Journal
of Drug and Alcohol Abuse, 29(1), 75-104. (28.23)
Grella, C. E. (1996). Background and overview of mental health
and substance abuse treatment systems: Meeting the needs of women
who are pregnant or parenting. Journal of Psychoactive Drugs,
28(4), 319-343. (21.17)
Grella, C. E. (1994). Contrasting a shelter and day center for
homeless mentally ill women: Four patterns of service use. Community
Mental Health Journal, 30(1), 3-16. (15.3)
Grella, C. E. (2003). Contrasting the views of substance misuse
and mental health treatment providers on treating the dually diagnosed.
Substance Use and Misuse, 38(10), 1433-1446. (15.17)
Grella, C. E. (2003). Effects of gender and diagnosis on addiction
history, treatment utilization, and psychological functioning
among a dually-diagnosed sample in drug treatment. Journal
of Psychoactive Drugs, SARC Supplement 1, 169-179. (15.16)
Grella, C. E. (1993). A residential recovery program for homeless
alcoholics: Differences in program recruitment and retention.
Special section: Alcohol and drug abuse services for homeless
populations. Journal of Mental Health Administration, 20(2),
90-99. (02.8)
Grella, C. E. (1997). Services for perinatal women with substance
abuse and mental health disorders: The unmet need. Journal
of Psychoactive Drugs, 29(1), 67-78. (21.25)
Grella, C. E. (1999). Women in residential drug treatment: Differences
by program type and pregnancy. Journal of Health Care for
the Poor and Underserved, 10(2), 216-229. (21.22)
Grella, C. E., & Anglin, M. D. (1994). Implementing an enhanced
methadone maintenance program for HIV risk reduction in Los Angeles.
In: B. W. Fletcher, J. A. Inciardi, & A. M. Horton (Eds.),
Drug abuse treatment: The implementation of innovative approaches
(pp. 3-18). Westport, CT: Greenwood Press. (10.16)
Grella, C. E., Anglin, M. D., & Annon J. J. (1996). HIV risk
behaviors among women in methadone maintenance treatment. Substance
Use and Misuse, 31(3), 277-301. (10.24)
Grella, C. E., Anglin, M. D., Rawson, R., Crowley, R., & Hasson,
A. (1996). What happens when a demonstration project ends. Consequences
for a clinic and its clients. Journal of Substance Abuse Treatment,
13(3), 249-256. (10.26)
Grella, C. E., Anglin, M. D., & Wugalter, S. E. (1995). Cocaine
and crack use and HIV risk behaviors among high-risk methadone
maintenance clients. Drug and Alcohol Dependence, 37(1),
15-21. (10.22)
Grella, C. E., Anglin, M. D., & Wugalter, S. E. (1997). Patterns
and predictors of cocaine and crack use by clients in standard
and enhanced methadone maintenance treatment. American Journal
of Drug and Alcohol Abuse, 23(1), 15-42. (10.28)
Grella, C. E., Anglin, M. D., Wugalter, S. E., & Annon, J.
J. (1997). The effectiveness of the Los Angeles enhanced methadone
maintenance project: Reducing HIV risk among injection drug users.
In: F. M. Tims, J. A. Inciardi, B. W. Fletcher, & A. M. Horton
(Eds.), The effectiveness of innovative approaches in the
treatment of drug abuse (pp. 17-32). Westport, CT: Greenwood
Press. (10.29)
Grella, C. E., Anglin, M. D., Wugalter, S. E., Rawson, R., &
Hasson, A. (1994). Reasons for discharge from methadone maintenance
for addicts at high risk of HIV infection or transmission. Journal
of Psychoactive Drugs, 26(2), 223-232. (10.20)
Grella, C. E., Annon, J. J., & Anglin, M. D. (2000). Drug
use and risk for HIV among women arrestees in California. AIDS
and Behavior, 4(3), 289-295. (01.48)
Grella, C. E., Annon, J. J., & Anglin, M. D. (1995). Ethnic
differences in HIV risk behaviors, self-perceptions, and treatment
outcomes among women in methadone maintenance treatment. Journal
of Psychoactive Drugs, 27(4), 421-433. (09.11)
Grella, C. E., Campos, M., & Anglin, M. D. (1998). Relationship
of HIV testing and high-risk behaviors among clients in methadone
maintenance treatment. AIDS Education and Prevention, 10(5),
403-416. (10.27)
Grella, C. E., Chaiken, S., & Anglin, M. D. (1995). A procedure
for assessing the validity of self-report on data on high-risk
sex behaviors from heroin addicts entering free methadone treatment.
Journal of Drug Issues, 25(4), 723-733. (10.19)
Grella, C. E., Etheridge, R. M., Joshi, V., & Anglin, M. D.
(2000). Delivery of HIV risk-reduction services in drug treatment
programs. Journal of Substance Abuse Treatment, 19(3),
229-237. (01.23)
Grella, C. E., & Gilmore, J. (2002). Improving service delivery
to the dually diagnosed in Los Angeles County. Journal of
Substance Abuse Treatment, 23, 115-122. (15.14)
Grella, C. E., & Hser, Y. (1997). A county survey of mental
health services in drug treatment programs. Psychiatric Services,
48(7), 950-952. (15.5)
Grella, C. E., Hser, Y., Joshi, V., & Anglin, M. D. (1999).
Patient histories, retention and outcome models for younger and
older adults in DATOS. Drug and Alcohol Dependence, 57(2),
151-166. (18.81)
Grella, C. E., Hser, Y., Joshi, V., & Rounds-Bryant, J. (2001).
Drug treatment outcomes for adolescents with comorbid mental and
substance use disorders. Journal of Nervous and Mental Disease,
189(6), 384-392. (05.12)
Grella, C. E., & Joshi, V. (1999). Gender differences in drug
treatment careers among clients in the National Drug Abuse Treatment
Outcome Study. American Journal of Drug and Alcohol Abuse,
25(3), 383-404. (14.7)
Grella, C. E., & Joshi, V. (2003). Treatment processes and
outcomes among adolescents with a history of abuse who are in
drug treatment. Child Maltreatment, 8(1), 7-18. (05.20)
Grella C.E., Joshi, V., & Anglin, M. D. (2003). Gender differences
and treatment outcomes among methadone patients in the Drug Abuse
Treatment Outcome Study. Journal of Maintenance in the Addictions,
2(1/2), 103-128. (10.42)
Grella, C. E., Joshi, V., & Hser, Y. (2000). Program variation
in treatment outcomes among women in residential drug treatment.
Evaluation Review, 24(4), 364-383. (21.29)
Grella, C. E., Perry, S. M., & Anglin, M. D. (1996). Drug
and alcohol treatment programs for women: Client characteristics,
program characteristics, and treatment outcomes. Rockville,
MD: Center for Substance Abuse Treatment, National Evaluation
Data and Technical Assistance Center. (21.18)
Grella, C. E., Polinsky, M. L., Hser, Y., & Perry, S. M. (1999).
Characteristics of women-only and mixed-gender drug abuse treatment
programs. Journal of Substance Abuse Treatment, 17(1-2),
37-44. (18.77)
Grella, C.E., Scott, C.K., Foss, M.A., Joshi, V., & Hser,
Y.I. (2003). Gender differences in drug treatment outcomes among
participants in the Chicago Target Cities Study. Evaluation
and Program Planning, 26(3), 297-310. (14.16)
Grella, C. E., Wugalter, S. E., & Anglin, M. D. (1997). Predictors
of treatment retention in enhanced and standard methadone maintenance
treatment for HIV risk reduction. Journal of Drug Issues,
27(2), 203-224. (10.31)
Gresenz, C. R., Watkins, K. E., & Podus, D. (1998). Supplemental
Security Income (SSI), Disability Insurance (DI), and substance
abusers. Community Mental Health Journal, 34(4), 337-350.
(26.05)
Gresenz, C. R., Watkins, K. E., & Podus, D. (1997). Supplemental
security income (SSI), disability insurance (DI), substance abusers:
The impact of benefit termination. Los Angeles: University of
California, Los Angeles and RAND. (20.12)
Gresenz, C. R., Watkins, K. E., Podus, D., & Anglin, M. D.
(1997). Benefits for substance abusers repealed: Impact in California
(Policy Brief). Los Angeles: UCLA Center for Health Policy Research.
(13.13)
Grills, C., & Longshore, D. (1996). Africentrism: Psychometric
analyses of a self-report measure. Journal of Black Psychology,
22(1), 86-106. (09.8)
Last updated - 02/11/2010